Nierenzellkarzinom onkowissen

Nierenzellkarzinom onkowissen
Nierenzellkarzinom onkowissen
Developer: onkowissen
Category: Medical
Add App to Comparison
824 installs
Ratings not yet available
39 monthly active users
Revenue not available
Install Trends
Weekly +4.00
Trending
Monthly +12
Steady

Nierenzellkarzinom onkowissen Summary

Nierenzellkarzinom onkowissen is a mobile Android app in Medical by onkowissen. Released in Dec 2018 (7 years ago). It has about 824+ installs Based on AppGoblin estimates, it reaches roughly 39 monthly active users . Store metadata: updated Sep 18, 2025.

Recent activity: 4.00 installs this week (12 over 4 weeks) showing above average growth View trends →

Store info: Last updated on Google Play on Sep 18, 2025 .

SDKs, Trackers & Permissions

App not yet scanned for SDKs.

App Details
Store ID: de.onkowissen.nierenzellkarzinom
First Released: 2018-12-20
Store Last Updated: 2025-09-18
In-App Purchases: No
Ads: No
Website: nierenzellkarzinom.onkowissen.de
App Store
Crawl Status: Success
AppGoblin First Crawled: 2024-08-26
AppGoblin Last Crawled: 2026-03-07
Ads & App-Ads.txt
App does not have ads.
AppGoblin SDK Scans
App not yet analyzed for SDKs.

The download and scan process is automated but can require manual troubleshooting. Feel free to reach out if your request does not complete in 24hrs or if you have any questions.


0★

Ratings: 0

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot

App Description

The app "onco-knowledge renal cell carcinoma": innovative - interactive - educational

The onco-knowledge renal cell carcinoma app offers you quick, easy and up-to-date access to extensive, practice-relevant information on the diagnosis and treatment of renal cell carcinoma.

Find answers to your questions on the following topics:
- Diagnosis of renal cell carcinoma
- Therapy algorithm
- Therapy management
- Approved Substances
- Interactions
- Guidelines
- Aftercare
- Tools/Services

This app is intended only for professionals with an onkowissen.de login. The app serves exclusively as an information basis for the treatment of renal cell carcinoma.